Lantern Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
4,670
+97
+2% +$22.6K 0.54% 46
2026
Q1
$1.12M Buy
4,573
+67
+1% +$15.6K 0.57% 45
2025
Q4
$933K Buy
4,506
+210
+5% +$41.5K 0.5% 54
2025
Q3
$797K Sell
4,296
-758
-15% -$130K 0.42% 61
2025
Q2
$772K Buy
+5,054
New +$777K 0.46% 61
2024
Q4
$746K Sell
5,159
-203
-4% -$31.5K 0.48% 51
2024
Q3
$869K Sell
5,362
-92
-2% -$14.7K 0.6% 44
2024
Q2
$797K Buy
5,454
+10
+0.2% +$1.49K 0.58% 46
2024
Q1
$861K Sell
5,444
-26
-0.5% -$4.14K 0.61% 48
2023
Q4
$857K Buy
+5,470
New +$839K 0.67% 45

Other funds holding JNJ

Lantern Wealth Advisors's JNJ Position: Q2 2026 in Review

Lantern Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 2.1% in Q2 2026, buying an estimated $22.6K and bringing the position to 4,670 shares worth $1.19M. The position accounts for 0.54% of the portfolio, ranked #46.

Lantern Wealth Advisors first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Lantern Wealth Advisors held 4,670 shares of Johnson & Johnson worth $1.19M as of Q2 2026.
  • Lantern Wealth Advisors bought 97 Johnson & Johnson shares in Q2 2026, an estimated $22.6K.
  • Johnson & Johnson made up 0.54% of Lantern Wealth Advisors's portfolio in Q2 2026, its #46 holding.
  • Lantern Wealth Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Lantern Wealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.